Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2023-11-20 | 2023-09 | 0 | N/A | N/A | N/A |
2023-05-10 | 2023-03 | 0 | N/A | N/A | N/A |
2023-04-17 | 2022-12 | 0 | N/A | N/A | N/A |
2022-11-21 | 2022-09 | -4.8 | N/A | N/A | N/A |
2022-11-10 | 2022-06 | 0 | N/A | N/A | N/A |
2022-05-23 | 2022-03 | -7.21 | N/A | N/A | N/A |
Split | Date |
---|---|
1 : 30 | 2023-05-17 |
1 : 10 | 2020-09-08 |
1 : 30 | 2018-07-10 |
1 : 3 | 2016-09-29 |
-
.60 test for massive explosion
-
Just hold people
-
Quite underestimated in my opinion...
-
Woowwwww!!! This is BiG as in!!!
-
Dumping sell your share before down to .30
-
April 15
-
Even more arguments that this one will riseup fast!!
-
You guys are silly, do your DD, stick to your strategy, set your PT and leave your emotions at the door,... this is business, professional comment only please, thank you...
-
Right on. Add tuna!
-
Just like I posted before this is great news and will make it run, but just wait till they break the antibody testing PR. If you’re not in you will regret it.
-
Yes please, can’t wait for monday. I cant believe I almost sold that one before closing
-
Wait next week when the antibody testing news comes out!
-
$1(162k) $1.80 (186k)
-
Walls at .42 (113k)/.45 (121k)
-
Watch the size of the buy at the last second!!!!
This will tell the story -
Monday morning will be exciting!! ️
-
8 minutes and counting lol
-
$BIOC
What will the shorts do now
Hahahaha -
$BIOC
It’s definitely true -
You ain’t getting my shares. See you Monday
-
Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics
businesswire.com • -
Biocept to Participate in the H.C. Wainwright Global Investment Conference
businesswire.com • -
Biocept, Inc. (BIOC) Business Update Conference Call (Transcript)
seekingalpha.com • -
Biocept to Hold Business Update Conference Call on August 30, 2023
businesswire.com • -
7 F-Rated Biotech Stocks You Shouldn't Touch With a 10-Foot Pole
investorplace.com • -
Biocept Reports Second Quarter 2023 Financial Results
businesswire.com • -
Biocept CNSide assay takes the spotlight at 2023 SNO/ASCO CNS Cancer Conference
proactiveinvestors.com • -
Biocept Announces the Passing of Board Chair M. Faye Wilson
businesswire.com • -
Biocept appoints Antonino Morales as president and chief executive officer
proactiveinvestors.com • -
Biocept Names Antonino Morales as President and Chief Executive Officer
businesswire.com • -
Why Is Biocept (BIOC) Stock Down 42% Today?
investorplace.com • -
Biocept Announces Pricing of $5.0 Million Underwritten Public Offering
businesswire.com • -
Biocept shares to commence trading on split-adjusted basis
proactiveinvestors.com • -
Biocept Announces One-for-Thirty Reverse Stock Split
businesswire.com • -
Biocept Announces One-for-Thirty Reverse Stock Split
businesswire.com •